Jaguar Health (NASDAQ: JAGX) stock plunged 35% in intraday trading Monday as the company prepares to implement a reverse stock
2 years ago
Jaguar Health (NASDAQ: JAGX) stock jumped about 16% in intraday trading after the company submitted clinical trial applications for Crofelemer
Jaguar Health (NASDAQ: JAGX) stock is garnering attention following the appointment of a new Senior Vice President (SVP) of Growth
Jaguar Health (NASDAQ: JAGX) stock soared over 50% in intraday trading after the company inked an exclusive 5-year in-license agreement
Jaguar Health (NASDAQ: JAGX) stock plunged over 5% in the pre-market trading Tuesday after the company reported a year-over-year decline
Jaguar Health (NASDAQ: JAGX) stock soared following the announcement that GEN will commercialize Jaguar’s crofelemer in Turkey and eight neighboring
Jaguar Health (NASDAQ: JAGX) stock soared 50% on Friday without any company-specific news for the session. Jaguar Health (JAGX) disclosed
